Last updated at 20 Jun 2024 07:01 PM
Director
DIN: 05226029
Samit Hegde is currently associated with 2 companies in various capacities such as Managing Director and Director. They serve as a Director at NANDU CHEMICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05226029.Samit Hegde has previously been associated with 1 company in roles such as Additional Director and Whole-time director.Samit Hegde is currently involved in 2 different roles. Their most recent position is with NANDU PHARMA PRIVATE LIMITED as a Director. The first company Samit Hegde was appointed to as a director was NANDU CHEMICALS PRIVATE LIMITED. Samit Hegde is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Samit Hegde is currently associated with 2 companies in various capacities such as Managing Director and Director. They serve as a Director at NANDU CHEMICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05226029.Samit Hegde has previously been associated with 1 company in roles such as Additional Director and Whole-time director.Samit Hegde is currently involved in 2 different roles. Their most recent position is with NANDU PHARMA PRIVATE LIMITED as a Director. The first company Samit Hegde was appointed to as a director was NANDU CHEMICALS PRIVATE LIMITED. Samit Hegde is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
2y 9m 1y 5m Interval
Company Name | Designation | Date of Appointment |
---|---|---|
NANDU CHEMICALS PRIVATE LIMITED | Managing Director | 01-Oct-2021 |
NANDU PHARMA PRIVATE LIMITED | Director | 10-Nov-2022 |